Early Phase 1 Liver Cancer Trial, Recruiting NCT07193862 Sponsor: Northwell Health Condition: Liver Cancer
Back to Liver Cancer

Early Phase 1 Liver Cancer Trial, Recruiting

NCT07193862
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with colorectal cancer (confirmed by a lab test on tissue) and scans show it may have spread to the liver
  • The liver tumor is at least 2 cm in size, as seen on a CT or MRI scan
  • Your doctors have already planned surgery to remove part of your liver as part of your standard treatment, regardless of this study
  • You are 18 years of age or older
  • Your blood counts and organ function are within acceptable ranges (for example, healthy enough white blood cells, platelets, and kidney function — confirm specific values with trial site)
  • Your blood clotting levels are within acceptable ranges (confirm with trial site)
  • The surgical team and radiology team have determined that a small medical device can safely be placed in your tumor based on its size and location
  • If you are a woman who could become pregnant, you must have a negative blood pregnancy test within 48 hours before your operation
  • You are able to understand and willing to sign a consent form for both the surgery and the research study before any procedures begin
  • If you are able to have children (male or female), you must agree to use effective birth control starting before treatment and for at least 3 months (men) or 6 months (women) after the device is placed
  • If you are breastfeeding, you must agree to stop breastfeeding for 14 days after the device is inserted

Who may not be able to join:

  • The location of your tumor makes it impossible to place the small medical device
  • You are pregnant at the time of joining the trial or at the time of surgery, because the medications involved are known to be harmful to an unborn baby
  • You have had or currently have a second, separate cancer whose history or treatment could affect the safety or results of this study
  • Your cancer has spread outside the liver, or the liver tumors cannot be fully removed by surgery, based on your baseline scans

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Northwell Health
Registry
ClinicalTrials.gov
Start date
10 December 2025
Est. completion
15 April 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Incidence of adverse events (AEs) associated with Microdevice placement and retrieval

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov